Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Lifeward Ltd. Director's Dealing 2023

Sep 19, 2023

35158_dirs_2023-09-19_e6c3ae87-18cb-417a-9631-64529540b6a1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ReWalk Robotics Ltd. (RWLK)
CIK: 0001607962
Period of Report: 2023-09-13

Reporting Person: Dykan Jeff (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-09-13 Ordinary Shares, par value NIS 0.25 per share A 59595 $0.00 Acquired 119157 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Ordinary Shares, par value NIS 0.25 per share 65655 Indirect
Ordinary Shares, par value NIS 0.25 per share 50000 Direct

Footnotes

F1: Represents 59,595 ordinary shares, par value NIS 0.25 per share, issuable upon the vesting of restricted stock units ("RSUs") granted on September 13, 2023 (the "Grant Date") under the ReWalk Robotics Ltd. Amended and Restated 2014 Incentive Compensation Plan. The RSUs vest ratably in four equal quarterly installments starting three months following the Grant Date.

F2: Consists of 50,488 Ordinary Shares beneficially owned by SCP Vitalife Partners II, L.P. ("SCP Vitalife Partners II"), a limited partnership organized in the Cayman Islands, 13,596 Ordinary Shares beneficially owned by SCP Vitalife Partners (Israel) II, L.P. ("SCP Vitalife Partners Israel II"), a limited partnership organized in Israel, and 1,571 ordinary shares held by the Israel Innovation Authority (the "IIA"), that Vitalife Partners Overseas, Vitalife Partners Israel and Vitalife Partners DCM have the right to acquire from IIA. The reporting person is therefore deemed to beneficially own 65,655 shares of ReWalk Robotics Ltd.